Orange Book product · Brand (NDA)
ZANAFLEX
TIZANIDINE HYDROCHLORIDE
At a glance
Feb 04, 2000
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 04, 2000
26 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
TIZANIDINE HYDROCHLORIDE
Strength
EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 020397
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024ONTRALFYBrand (NDA)
NDA 216190 · FIDELITY BIOPHARMA
- 2002ZANAFLEXBrand (NDA)
NDA 021447 · LEGACY PHARMA USA
- 2024TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218920 · RISING
- 2024TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213365 · SENORES PHARMS
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213798 · RUBICON RESEARCH
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213544 · AUROBINDO PHARMA LTD
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213223 · ALEMBIC
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212196 · ALKEM LABS LTD
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210021 · CADILA PHARMS LTD
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210267 · INGENUS PHARMS LLC
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211798 · ALKEM LABS LTD
- 2018TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208187 · CADILA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

